In this panel discussion at the 2024 Precision Medicine Tri-Conference, BLOODPAC members working in the cancer early detection space will explore the challenges and best practices for clinical validation of MCED assays.

Panelists:

Kathyrn Lang, Senior Vice President, Real-World Data and Analytics, Freenome

J. Carl Barrett, PhD, Professor, University of North Carolina

Alexey Aleshin, MD, General Manager, Oncology and Early Cancer Detection; CMO, Natera, Inc.